CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

31 hedge funds and large institutions have $2.45M invested in CASI Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 2 closing their positions.

Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$20K
2
WSC
2
Wellington Shields & Co
New York
$561K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$68K
4
Bank of America
4
Bank of America
North Carolina
$4K
5
BIM
5
BlackRock Investment Management
Delaware
$4K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$407K
2
Goldman Sachs
2
Goldman Sachs
New York
$27K
3
WSCM
3
Wellington Shields Capital Management
New York
$619K
4
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$1K
5
UBS Group
5
UBS Group
Switzerland
$1K
Name Market Value Shares Shares
Change 		Shares
Change %
SCM
26
Southport Capital Management
Tennessee
– – -19 Closed
AG
27
Advisor Group
Arizona
$0 130 – –
NFG
28
Next Financial Group
Texas
$0 2 – –
FWM
29
Focused Wealth Management
New York
$0 45 – –
Deutsche Bank
30
Deutsche Bank
Germany
$0 21 – –
CPIG
31
Chicago Partners Investment Group
Illinois
$0 27 – –
Creative Planning
32
Creative Planning
Kansas
$0 9 – –
Wells Fargo
33
Wells Fargo
California
$0 80 – –
1
2